Skip to main content
ABT logo
ABT
(NYSE)
Abbott Laboratories
$87.83-- (--)
Loading... - Market loading

Abbott Laboratories (ABT) Stock Price & Financial Analysis

Abbott Laboratories Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$87.21 - $88.59
52-Week High$139.06
52-Week Low$81.97
Open$88.15
Volume10.75M
Average Volume (3M)13.07M
Market Cap154.46B
Shares Outstanding1.75B
P/E Ratio (TTM)24.61
Forward P/E49.26
Price to Sales (P/S)3.42
Price to Book (P/B)2.97
EV/EBITDA16.35
Revenue (TTM)45.13B
Net Income (TTM)6.28B
Free Cash Flow (TTM)7.38B
EPS (TTM)$3.59
Profit Margin13.91%
Operating Margin17.07%
Return on Equity (ROE)12.06%
Debt to Equity0.65
50-Day MA$90.13
200-Day MA$113.64
52-Week Change-33.23%
Annual Dividend$2.44
Dividend Yield2.76%
Payout Ratio67.98%
Last Dividend Ex-DateJul 15, 2026

Frequently Asked Questions About Abbott Laboratories

What is the current stock price for ABT?

As of the latest trading session, ABT stock trades at $87.83. The 52-week range is $81.97–$139.06, with a day range of $87.21–$88.59.

What is the P/E ratio for ABT?

Abbott Laboratories's trailing P/E ratio is 24.6, meaning investors pay $24.6 for every $1 of annual earnings. The forward P/E is 49.3, reflecting analyst expectations for future earnings. Abbott Laboratories operates in the Healthcare sector.

Does ABT pay dividends?

Yes, Abbott Laboratories pays a 2.76% annual dividend yield ($2.44 per share). The payout ratio is 68.0%. The last ex-dividend date was 2026-07-15.

What do analysts recommend for ABT?

Based on 28 analysts, the consensus for ABT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABT?

Abbott Laboratories's market capitalization is $153.45B, classifying it as a large-cap company. Abbott Laboratories operates in the Healthcare sector within the Medical Devices industry.